Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 16214062)

Published in Phys Med Rehabil Clin N Am on November 01, 2005

Authors

Simone Abmayr1, Patrick Weydt

Author Affiliations

1: Department of Neurology, University of Washington, 1959 NE Pacific Street Seattle, WA 98195, USA.

Articles citing this

Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron (2010) 7.87

Articles by these authors

Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care (2004) 1.11

A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet (2012) 1.06

The role of PGC-1α in the pathogenesis of neurodegenerative disorders. Curr Drug Targets (2010) 0.98

Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol Dis (2013) 0.96

PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.96

Medicinal cannabis: rational guidelines for dosing. IDrugs (2004) 0.94

Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. J Neurochem (2004) 0.94

Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol (2014) 0.90

Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy. Expert Opin Pharmacother (2004) 0.87

Development, implementation, and evaluation of a movie-based curriculum to teach psychopathology. Teach Learn Med (2014) 0.84

Can lesions to the motor cortex induce amyotrophic lateral sclerosis? J Neurol (2013) 0.84

Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. Neuroreport (2004) 0.82

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care (2005) 0.81

Drug therapy for amyotrophic lateral sclerosis: Where are we now? IDrugs (2003) 0.79

Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs (2002) 0.78

Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases. Neurodegener Dis (2013) 0.77

Progranulin bridges energy homeostasis and fronto-temporal dementia. Cell Metab (2012) 0.76

Targeting toxic proteins for turnover. Nat Med (2005) 0.75

Full-length PGC-1α salvages the phenotype of a mouse model of human neuropathy through mitochondrial proliferation. Hum Mol Genet (2013) 0.75

Electrodiagnostic evaluation of hereditary motor and sensory neuropathies. Phys Med Rehabil Clin N Am (2003) 0.75